NCT07110571 A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer Status RECRUITING Phase PHASE2
NCT07101666 Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT07098949 Acupuncture Combined With Chemotherapy for Gastric Cancer After Surgery Status NOT_YET_RECRUITING Phase NA
NCT07085273 Irinotecan Liposome II + 5-FU/LV + Oxaliplatin + Karelizumab in Neoadjuvant Treatment of Gastric Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT07080879 The Advantages and Disadvantages of Linear Anastomat and Tubular Anastomat in Radical Gastrectomy of Distal Gastric Cancer Status ACTIVE_NOT_RECRUITING Phase NA
NCT07076979 Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Gastric Cancer:MetBio-GC Status RECRUITING Phase N/A
NCT07072429 Annual Hospital Volume and and Short-term Postoperative Outcomes After Gastric Cancer Resection Status COMPLETED Phase N/A
NCT07069842 The Construction of a Predictive Model for Gastric Cancer Immunotherapy Response Based on Tumor-Infiltrating Lymphocytes (TILs) and Histone H3K4me3 in the Tumor Microenvironment Status RECRUITING Phase N/A
NCT07067983 Clinical Evaluation of GRAPE Model for Gastric Cancer Screening Status RECRUITING Phase N/A
NCT07066657 A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT07056010 Efficacy and Safety of Minimally Invasive D2+PAND Gastrectomy for Gastric Cancer With PAN Metastasis After Conversion Immunochemotherapy Status RECRUITING Phase NA
NCT07032961 A Cohort Study of Mobile Capsule Gastroscopy for Gastric Pathologies Screening Status RECRUITING Phase N/A
NCT07025889 IBI343 Combined With Sintilimab Plus Chemotherapy in Gastric Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT07018661 [18F]F-FAPI PET/CT and Laparoscopy in Staging Advanced Gastric Cancer Status RECRUITING Phase PHASE2/PHASE3
NCT07001592 Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors Status RECRUITING Phase PHASE1
NCT06999187 A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas Status RECRUITING Phase PHASE1
NCT06988475 DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations Status RECRUITING Phase PHASE2/PHASE3